Atomera

Atomera

Atomera was founded in 2001 as Mears Technologies by Robert Mears and a team of semiconductor engineers who believed the periodic table still held room for improvement. The firm spent over a decade in stealth, developing and patenting a process that applies a thin film of oxygen-doped silicon at the atomic level to improve transistor performance. After its 2016 IPO on the Nasdaq under the ticker ATOM, the company shifted from R&D curiosity to commercial licensing, now operating out of Los Gatos, California. The company's sole technology, Mears Silicon Technology (MST), functions as a transistor enhancement layer that can be inserted into standard CMOS manufacturing without retooling fabs. MST has been proven to improve power efficiency by up to 15%, transistor variability by up to 50%, and chip speed by up to 20% according to data the firm presented at the International Electron Devices Meeting (per Semiconductor Engineering, 2024). Atomera targets foundries producing chips on mature 28nm to 65nm nodes, a deliberate choice to serve the massive analog, power-management, and RF chip segments where advanced-node EUV lithography is not economical. Publicly disclosed license agreements and partnerships include STMicroelectronics and the R&D foundry CEA-Leti in France, alongside ongoing qualification engagements with undisclosed top-tier foundries in Asia. The company is led by CEO Scott Bibaud, a veteran of Broadcom and Altera, and CTO Robert Mears. Atomera operates with a lean R&D and licensing team; it reported 24 full-time employees in its 2023 annual filing, avoiding the capital intensity of owning a fab. Its revenue model is entirely IP-based, with income recognized through integration license fees, milestone payments, and long-term royalty streams per wafer produced. In September 2023, Atomera announced the first commercial license agreement for its MST technology with an undisclosed semiconductor manufacturer, marking the transition from R&D evaluations to revenue-generating deployment (per the firm, September 2023). Atomera's structural differentiator lies in its position as a pure-play transistor IP licensor — a business model more common in semiconductor architectures like ARM than in materials science. By decoupling transistor research from fabrication, the firm forces a licensing conversation that large integrated device manufacturers typically keep inside their own R&D walls. Whether the foundry giants ultimately adopt or bypass exogenous materials innovation defines the investment case.